Exosome-Depleted MiR-148a-3p Derived from Hepatic Stellate Cells Promotes Tumor Progression Through ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma
Xiangyu Zhang(Taiyuan University of Technology), Zheng Wang(Union Hospital), Lei Yu(Taiyuan Central Hospital), Yuan‐Fei Peng(Fudan University), Xinyu Wang(Cancer Institute (WIA)), Jian Zhou(Shenzhen University Health Science Center), Feiyu Chen(Cancer Institute (WIA)), Jia Fan(Nanjing Tech University), Cheng Zhou(Second Affiliated Hospital of Zhejiang University), Jie Hu(Brigham and Women's Hospital), Kaiqian Zhou(Ministry of Education), Peiran Huang(Fudan University)
Cited by 0
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644